Σύνολο αποτελεσμάτων: 94, εμφανίζονται 1 - 10
Αποτελέσματα ανά σελίδα:  10  25  50  100
Ταξινόμηση ανά: Ημερομηνία · Επισκέψεις · Τίτλο
1 Advances in genetics of IBD: the NOD2/CARD15 gene
Kollias, root,
During the last few years, significant advances have been achieved in the understanding of the pathogenesis of inflammatory bowel diseases (IBD). By gaining new insights, paradigms that seemed to be a...
2 AIDS-Related diarrhea– pathogenesis, evaluation and treatment
Zacharof A., .,
SUMMARY As the AIDS epidemic continues to spread and involve all segments of society, more and more internists and gastroenterologists are called upon to evaluate and treat patients with disabling dia...
3 Alcoholic liver disease
Afroudakis A., .,
4 Argon plasma coagulation: Clinical applications in Gastroenterology
P. Sechopoulos, Th. Rokkas, J. Robotis,,
SUMMARY Argon plasma coagulation (APC) is a method of non-contact endoscopic thermal coagulation. According to recent data, it can safely be used in clinical practice and there are indications that AP...
5 Azathioprine/6-mercaptopurine toxicity: The role of the TPMT gene
KH. K.H. Katsanos EV. Tsianos,
The thiopurine drugs azathioprine (AZA) and 6-mercaptopurine (6-MP) are widely used in medicine, including inflammatory bowel diseases (IBD). Thiopurine drugs undergo S-methylation catalysed by thiopu...
6 Budd-Chiari syndrome
A.V. Kyriakidis I. Vezyrgiannis M. Pyrgioti,
The Budd-Chiari syndrome is characterized by thrombotic or non thrombotic reduction of the venous hepatic flow. Several works have enabled the comprehension of Budd-Chiari syndrome as well as the diag...
7 Chemotherapy for esophageal cancer;should it be offered to all patients?
S.N. Sgouros A. Mantides,
Esophageal cancer presents a rising incidence worldwide with poor outcome in most of the cases. The traditional approach has been esophagectomy for surgically respectable tumors and palliative treatme...
8 Chronic hepatitis C and no response to antiviral therapy:A perpetual problem
Papatheodoridis G., Cholongitas, E.,
SUMMARY No-response to antiviral therapy was observed in the majority of chronic hepatitis C patients treated with interferon alpha (IFN-a) monotherapy, but continues to represent a frequent problem e...
9 Clinical Trials– Past, Present and Future
., D.P. Jewell,